Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11760736 Processes and intermediates for preparing MCL1 inhibitors

Patent 11760736 was granted and assigned to Gilead Sciences on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11760736

Patent Inventor Names

Darryl D. Dixon

Jeffrey E. Merit

Justin Y. Su

Luke D. Humphreys

Joshua R. Dunetz

Marshall D. Young

Greg Cizio

Valerie Huynh

...

Date of Patent

September 19, 2023

Patent Application Number

17701404

Date Filed

March 22, 2022

Patent Citations

‌

US Patent 10703733 MCL-1 inhibitors

‌

US Patent 11325891 Processes and intermediates for preparing MCL1 inhibitors

‌

US Patent 10988451 MCL-1 inhibitors

Patent Primary Examiner

CPC Code

Patent abstract

The present disclosure provides methods for preparing MCL1 inhibitors or a salt thereof and related key intermediates.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11760736 Processes and intermediates for preparing MCL1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API